Literature DB >> 27429235

Verapamil, a Calcium-Channel Blocker, Improves the Wound Healing Process in Rats with Excisional Full-Thickness Skin Wounds Based on Stereological Parameters.

Soheil Ashkani-Esfahani1, Omid Koohi Hosseinabadi, Parinaz Moezzi, Yalda Moafpourian, Sina Kardeh, Shima Rafiee, Reza Fatheazam, Ali Noorafshan, Elham Nadimi, Shayan Mehrvarz, Mehdi Khoshneviszadeh, Mahsima Khoshneviszadeh.   

Abstract

OBJECTIVE: Calcium can play noticeable roles in the wound-healing process, such as its effects on organization of F-actinin collagen bundles by fibroblasts at the injury site. In addition, calcium-channel blockers such as verapamil have antioxidant activity by increasing nitric oxide production that promotes angiogenesis, proliferation of fibroblasts, and endothelial cells in the skin-regeneration process. Therefore, in this study, the authors' objective was to investigate the effects of verapamil on the process of wound healing in rat models according to stereological parameters.
MATERIALS AND METHODS: In this experimental study, 36 male Wistar rats were randomly divided into 3 groups (n = 12): the control group that received no treatment, gel-base-treated group, and the 5% verapamil gel-treated group. Treatments were done every 24 hours for 15 days. Wound closure rate, volume densities of the collagen bundles and the vessels, vessel's length density and mean diameter, and fibroblast populations were estimated using stereological methods and were analyzed by the Kruskal-Wallis and Mann-Whitney U tests; P < .05 was considered statistically significant.
RESULTS: The verapamil-treated group showed a faster wound closure rate in comparison with control and gel-base groups (P = .007 and P = .011). The numerical density of fibroblasts, volume density of collagen bundles, mean diameter, and volume densities of the vessels in the verapamil group were significantly higher than those in the control and the base groups (P < .005).
CONCLUSIONS: The authors showed that verapamil has the ability to improve wound healing by enhancing fibroblast proliferation, collagen bundle synthesis, and revascularization in skin injuries.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27429235     DOI: 10.1097/01.ASW.0000488666.03896.e6

Source DB:  PubMed          Journal:  Adv Skin Wound Care        ISSN: 1527-7941            Impact factor:   2.347


  6 in total

1.  Nitric Oxide Produced by the Antioxidant Activity of Verapamil Improves the Acute Wound Healing Process.

Authors:  Yu Na Han; Yoon Jae Lee; Ki Joo Kim; Su Jin Lee; Jang Youn Choi; Suk-Ho Moon; Jong Won Rhie
Journal:  Tissue Eng Regen Med       Date:  2021-01-29       Impact factor: 4.169

Review 2.  Mechanotransduction in Wound Healing and Fibrosis.

Authors:  Britta Kuehlmann; Clark A Bonham; Isabel Zucal; Lukas Prantl; Geoffrey C Gurtner
Journal:  J Clin Med       Date:  2020-05-11       Impact factor: 4.241

3.  Increased calcium channel in the lamina propria of aging rat.

Authors:  Ji Min Kim; Hyoung-Sam Heo; Sung-Chan Shin; Hyun-Keun Kwon; Jin-Choon Lee; Eui-Suk Sung; Hyung-Sik Kim; Gi Cheol Park; Byung-Joo Lee
Journal:  Aging (Albany NY)       Date:  2019-10-31       Impact factor: 5.682

4.  4-Aminopyridine Induces Nerve Growth Factor to Improve Skin Wound Healing and Tissue Regeneration.

Authors:  Mashanipalya G Jagadeeshaprasad; Prem Kumar Govindappa; Amanda M Nelson; Mark D Noble; John C Elfar
Journal:  Biomedicines       Date:  2022-07-08

5.  Effects of Azelnidipine-Carboxymethylcellulose Gel on Healing of Full-Thickness Skin Wounds in Streptozotocin Induced Diabetic Rats.

Authors:  Mohammad Yasin Karami; Nasrin Mansournia; Neda Bagherian; Alireza Makarem; Nader MoeinVaziri; Sahar Borna; Amir Hossein Pourdavood; Iman Shamohammadi
Journal:  Vet Med (Auckl)       Date:  2019-12-17

6.  Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains.

Authors:  Ellen K Wasan; Jinying Zhao; Joshua Poteet; Munawar A Mohammed; Jaweria Syeda; Kevin Soulsbury; Jacqueline Cawthray; Amanda Bunyamin; Chi Zhang; Brian M Fahlman; Ed S Krol
Journal:  Pharmaceutics       Date:  2019-11-09       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.